The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
暂无分享,去创建一个
M. Desruisseaux | L. Weiss | H. Tanowitz | S. Reznik | R. Stephani | F. P. Bruno | H. J. Shikani | B. Freeman | Minxian Dai